1. A126 SAFETY OF COMBINATION BIOLOGIC AND IMMUNOSUPPRESSIVE THERAPY POST-ORTHOTOPIC LIVER TRANSPLANTATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW. (15th March 2019) Authors: Al Draiweesh, S; Ma, C; Alkhattabi, M; Nguyen, T; Brahmania, M; Jairath, V Journal: Journal of the Canadian Association of Gastroenterology Issue: Volume 2(2019)Supplement 2 Page Start: 253 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A130 SAFETY OF COMBINATION BIOLOGIC AND ANTI-REJECTION THERAPY POST-LIVER TRANSPLANTATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: LONDON ONTARIO EXPERIENCE. (15th March 2019) Authors: Al Draiweesh, S; Ma, C; Alkhattabi, M; McDonald, C; Chande, N; Feagan, B G; Gregor, J C; Khanna, R; Marotta, P; Sandhu, A S; Qumosani, K; Teriaky, A; Brahmania, M; Jairath, V Journal: Journal of the Canadian Association of Gastroenterology Issue: Volume 2(2019)Supplement 2 Page Start: 260 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A225 THE UTILITY OF SEPARATE DISTAL AND MID-ESOPHAGEAL BIOPSIES IN THE DIAGNOSIS OF EOSINOPHILIC ESOPHAGITIS (EOE). (1st March 2018) Authors: Alkhattabi, M; Kubica, M; Driman, D; Gregor, J C Journal: Journal of the Canadian Association of Gastroenterology Issue: Volume 1(2018)Supplement 1 Page Start: 392 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A78 THE IMPACT OFGASTROINTESTINAL FOLLOW UP CARE ON HEALTHCARE UTILIZATION IN PATIENTS WITH ESINOPHILICESOPHAGITID (EOE). (4th March 2021) Authors: Alazemi, K; Alkhattabi, M; Gregor, J C Journal: Journal of the Canadian Association of Gastroenterology Issue: Volume 4(2021)Supplement 1 Page Start: 45 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A84 THE IMPACT OF GASTROINTESTINAL FOLLOW UP CARE ON HEALTHCARE UTILIZATION IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS (EOE). (4th March 2021) Authors: Alazemi, K; Alkhattabi, M; Gregor, J C Journal: Journal of the Canadian Association of Gastroenterology Issue: Volume 4(2021)Supplement 1 Page Start: 53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. DOP39 Safety of combination biologic and anti-rejection therapy post-liver transplantation in patients with inflammatory bowel disease: London Ontario experience. (25th January 2019) Authors: Al Draiweesh, S; Ma, C; Alkhattabi, M; Chande, N; Feagan, B G; Gregor, J C; Khanna, R; Marotta, P; Sandhu, A; Qumosani, K; Teriaky, A; Brahmania, M; Jairath, V Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S048 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P473 Contrasting the use of 5-ASA in patients with Ulcerative Colitis and Crohn's Disease: A cross-sectional analysis at a tertiary care IBD clinic. (16th January 2018) Authors: Alkhattabi, M; Jairath, V; Chande, N; Walton-Mennill, P; Gregor, J Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S343 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P666 Safety of combination biologic and immunosuppressive therapy post-orthotopic liver transplantation in patients with inflammatory bowel disease: a systematic review. (25th January 2019) Authors: Al Draiweesh, S; Ma, C; Alkhattabi, M; Nguyen, T; Brahmania, M; Jairath, V Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S452 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗